NeuroSense Therapeutics(NRSN) - 2023 Q4 - Annual Report

Exhibit 99.1 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | | Page | | --- | --- | | Report of Independent Registered Public Accounting Firm | F-2 | | Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-3 | | Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2023, 2022 and | F-4 | | 2021 | | | Consolidated Statements of Changes in Shareholders' Equity for the Years Ended December 31, 2023, 2022 and 2021 | F-5 | | Consolidated Statements of Cash Flows fo ...